Literature DB >> 30186051

Gastrointestinal Stromal Tumors of the Distal Gastrointestinal Tract.

Katherine A Kelley1, Raphael Byrne1, Kim C Lu1.   

Abstract

Gastrointestinal stromal tumors (GISTs) are rare in occurrence, but comprise the most common mesenchymal tumors of the gastrointestinal tract and affect between 15 and 20 individuals per million per year. Due to recent advancements in molecular classification of these tumors, medical therapy has provided improved outcomes to a historically surgically managed disease. This review article briefly discusses the molecular characteristics, medical and surgical therapies, and future of GIST management.

Entities:  

Keywords:  GIST management; gastrointestinal stromal tumors; mesenchymal tumors

Year:  2018        PMID： 30186051      PMCID： PMC6123010          DOI： 10.1055/s-0038-1642053

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN： 1530-9681


  49 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Prognostic factors for primary GIST: prime time for personalized therapy?

Authors:  Chandrajit P Raut; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2007-10-12       Impact factor: 5.344

3.  Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.

Authors:  Ronald P DeMatteo; Karla V Ballman; Cristina R Antonescu; Christopher Corless; Violetta Kolesnikova; Margaret von Mehren; Martin D McCarter; Jeffrey Norton; Robert G Maki; Peter W T Pisters; George D Demetri; Murray F Brennan; Kouros Owzar
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

4.  Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

Authors:  J A Crosby; C N Catton; A Davis; J Couture; B O'Sullivan; R Kandel; C J Swallow
Journal:  Ann Surg Oncol       Date:  2001 Jan-Feb       Impact factor: 5.344

5.  Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI.

Authors:  Christian Stroszczynski; Dominik Jost; Peter Reichardt; Petra Chmelik; Gunnar Gaffke; Albrecht Kretzschmar; Ulrike Schneider; Roland Felix; Peter Hohenberger
Journal:  Eur Radiol       Date:  2005-08-13       Impact factor: 5.315

6.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Authors:  Katherine A Janeway; Su Young Kim; Maya Lodish; Vânia Nosé; Pierre Rustin; José Gaal; Patricia L M Dahia; Bernadette Liegl; Evan R Ball; Margarita Raygada; Angela H Lai; Lorna Kelly; Jason L Hornick; Maureen O'Sullivan; Ronald R de Krijger; Winand N M Dinjens; George D Demetri; Cristina R Antonescu; Jonathan A Fletcher; Lee Helman; Constantine A Stratakis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 7.  Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues.

Authors:  Peter Reichardt; Pancras C W Hogendoorn; Elena Tamborini; Massimo Loda; Alessandro Gronchi; Andrés Poveda; Patrick Schöffski
Journal:  Semin Oncol       Date:  2009-08       Impact factor: 4.929

Review 8.  A systematic review on the clinical diagnosis of gastrointestinal stromal tumors.

Authors:  Marco Scarpa; Matteo Bertin; Cesare Ruffolo; Lino Polese; Davide F D'Amico; Imerio Angriman
Journal:  J Surg Oncol       Date:  2008-10-01       Impact factor: 3.454

9.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Authors:  Charles D Blanke; Cathryn Rankin; George D Demetri; Christopher W Ryan; Margaret von Mehren; Robert S Benjamin; A Kevin Raymond; Vivien H C Bramwell; Laurence H Baker; Robert G Maki; Michael Tanaka; J Randolph Hecht; Michael C Heinrich; Christopher D M Fletcher; John J Crowley; Ernest C Borden
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

Review 10.  Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease.

Authors:  Peter J Roberts; Burton Eisenberg
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162
View more
  4 in total

1.  Gastrointestinal stromal tumor with skeinoid fibers: an unusual presentation.

Authors:  A Trecca; F Ortica; G Marinozzi; R Borghini; C Camponi; A Baldi
Journal:  Tech Coloproctol       Date:  2018-11-24       Impact factor: 3.781

2.  Duodenojejunal intussusception secondary to primary gastrointestinal stromal tumor: A case report.

Authors:  Goshi Fujimoto; Shunichi Osada
Journal:  Int J Surg Case Rep       Date:  2019-09-30

3.  Colorectal Nonadenocarcinoma in South Korea.

Authors:  Jung Wook Huh
Journal:  Ann Coloproctol       Date:  2020-12-31

Review 4.  Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum.

Authors:  Alessandro Ottaiano; Mariachiara Santorsola; Francesco Perri; Ugo Pace; Bruno Marra; Marco Correra; Francesco Sabbatino; Marco Cascella; Nadia Petrillo; Monica Ianniello; Marika Casillo; Gabriella Misso; Paolo Delrio; Michele Caraglia; Guglielmo Nasti
Journal:  Biology (Basel)       Date:  2022-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.